Rationale: Natural killer (NK) cells are lymphocytes of the innate immune system that play specialized and nichespecific roles in distinct organs.
L eft ventricular (LV) remodeling after myocardial infarction (MI) results in LV dilation, a major cause of congestive heart failure and sudden cardiac death. MI causes sterile inflammation, which is characterized by the recruitment and activation of immune cells of the innate and adaptive immune systems. [1] [2] [3] These cells are likely to have cell type-specific functions in the time-course after MI that involves clearance of dead tissues, the reparative response, and adverse remodeling. [1] [2] [3] Disruption of myeloperoxidase (MPO), released predominantly by neutrophils, decreases leukocyte infiltration and LV dilation, enhances ventricular function, and delays early death attributable to myocardial rupture, 4 whereas macrophage depletion impairs wound healing and increases LV remodeling after MI. 1, 5 Dendritic cells are a potent immunoprotective regulator during the postinfarction healing process via their control of monocyte/macrophage homeostasis. 6 Treg cells serve to protect against adverse ventricular remodeling and contribute to improved cardiac function after MI via inhibition of inflammation and direct protection of cardiomyocytes. 7 γδT cells are the major source of interleukin (IL)-17 in the infarcted myocardium and function specifically in the late remodeling stages by promoting sustained infiltration of neutrophils and macrophages, stimulating macrophages to produce proinflammatory cytokines, aggravating cardiomyocyte death, and enhancing fibroblast proliferation and profibrotic gene expression via IL-17 production. 3 Natural killer (NK) cells (belonging to the group of innate lymphoid cells) are defined as large granular lymphocytes and constitute the third kind of cells differentiated from the common lymphoid progenitor generating B and T cells. 8 NK cells differ from NK T cells (NKT) phenotypically, by origin, and by respective effector functions. NK cells are cytotoxic lymphocytes critical to the innate immune system that can differentiate and mature in the bone marrow, lymph node, spleen, tonsils, and thymus before entering the circulation. In contrast to NKT cells, NK cells do not express invariant T-cell antigen receptors, Pan T marker CD3, or surface immunoglobulin (Ig) B cell receptors, but they usually express the surface markers CD16 (FcγRIII) and CD56 in humans, and NK1.1 in mice. NK cells play a highly important role in the killing of tumors and cells infected by viruses, and can have specialized and niche-specific functions in distinct organs.
In the present study, we sought to examine the roles of cardiac NK cells in the pathogenesis of LV remodeling after MI. Unexpectedly, depletion of NK cells from mice had little effect on LV remodeling after MI; however, these mice exhibited severe respiratory distress associated with protein-rich, high-permeability alveolar edema accompanied by neutrophil infiltration. Thus, we examined a mechanism for lung NK cells in protecting lung from the development of cardiogenic pulmonary edema after MI.
Methods
An expanded Materials and Methods section is available in the online Data Supplement.
Results

Genetic Ablation of NK Cells Exacerbated Cardiogenic Pulmonary Edema After MI
We used a mouse model of nonreperfused MI to examine the possible role of NK cells in the pathogenesis of cardiac remodeling after MI. A detailed temporal analysis of cellular infiltrate dynamics in the post-MI heart revealed an initial increase in the number of NK cells on day 3 after MI, to a peak on day 7 (Online Figure I ). In this study, we took advantage of the NKDTR/EGFP transgenic mice that express enhanced green fluorescent protein (EGFP) and the diphtheria toxin (DT) receptor under a functional NKp46 promoter, specifically in NK cells. 9 The complete and selective ablation of NK cells from the peripheral blood and lungs of NKDTR/EGFPtransgenic mice after DT treatment is shown in Online Figure IIA and IIB. Our previous studies have already proved that DT itself has no discernible cardiotoxic effects. 6 There was no difference in LV fractional shortening ( Figure 1A ), LV end-diastolic diameter ( Figure 1B ), gross morphology of the hearts ( Figure 1C ), infarct size ( Figure 1D . Ablation of NK cells did not affect cardiac function or infarct size. NK cells were depleted by diphtheria toxin (DT) injection 1 day before surgery to induce myocardial infarction (MI) in the transgenic mice that express enhanced green fluorescent protein (EGFP) and diphtheria toxin (DT) receptor under a functional NKp46 promoter (NKDTR/EGFP) mice. NK cells were then purified from wild-type and IL-10 knockout mice and transferred into the NKDTR/EGFP mice injected with DT. The echocardiographic analysis of fractional shortening (FS; A) and left ventricular end-diastolic diameter (LVEDD; B) at day 7 after the MI or sham operation (n=9-11) is shown. C, Azan staining of cardiac sections at day 7 after MI. Scale bar: 500 μm. D, Quantification of infarct size in the Azan-stained sections (n=9-11). NS indicates not significant. Statistical analysis was performed using Kruskal-Wallis tests followed by Bonferroni post hoc analysis. pressure [LVEDP], LV end-systolic pressure, +dP/dt, −dP/dt; Online Table I ) between PBS-treated and DT-treated NKDTR/ EGFP-transgenic mice. Adoptive transfer of NK cells into the transgenic mice from wild-type mice tended to improve the fractional shortening in hearts at 7 days post-MI although the effects were subtle.
Next, we examined the impact of NK-cell depletion on post-MI inflammation (Online Figure III) . The expression of cytokines, tumor necrosis factor-α, IL-6, and IL-1β in the infarcted myocardium was comparable between the PBS-and DT-treated NKDTR/EGFP-transgenic mice, whereas IFNγ expression was less in the DT-treated NKDTR/EGFPtransgenic mice than in the PBS-treated controls. Numbers of infiltrating CD45 + leukocytes, CD45 + CD11b + myeloid cells, CD45 + CD11b + F4/80 + macrophages, and Ly-6G + myeloid cells (neutrophils) were comparable between the 2 mice groups.
A large MI causes an elevation in LVEDP. Here, although the change in LVEDP was comparable between the PBS-treated NKDTR/EGFP-transgenic mice (13.3±5.1 mm Hg, P<0.05 versus baseline) and DT-treated NKDTR/EGFP-transgenic mice (14.1±4.6 mm Hg, P<0.05 versus baseline), arterial oxygen desaturation was significantly more prominent in the latter group (Online Table I ). In fact, DT-treated NKDTR/ EGFP-transgenic mice exhibited respiratory distress during the early phase after MI (Online Movie). In turn, adoptive transfer of NK cells rescued the arterial oxygen desaturation in DT-treated NKDTR/EGFP-transgenic mice. These results tempted us to speculate that lung NK cells play a protective role against cardiogenic pulmonary edema.
Development of Protein-Rich Alveolar Edema After MI
Then, we examined the quantitative time-course change in the profiles of bronchoalveolar lavage (BAL) fluid after MI. Pulmonary edema occurring because of an imbalance in Starling hydrostatic forces is theoretically accompanied by low-protein concentration fluid accumulation in the lung. However, BAL albumin ( Figure 2A ) and protein ( Figure 2B ) levels were elevated, peaking at day 7 post-MI, whereas BAL cell number also progressively increased to a maximum value at day 7 post-MI ( Figure 2C ). Flow cytometric analysis of immune cells in the lung infiltrate (Online Figure IV ) revealed a >2-fold increase in neutrophils by as early as 1 day post-MI that was sustained until day 7 after MI, whereas there was only a modest increase in alveolar macrophages ( Figure 2D ), and the number of dendritic cells gradually increased to a maximum value at day 14 post-MI. The neutrophil accumulation was associated with increased MPO activity in the bronchoalveolar lavage (BAL) fluid ( Figure 2E ), and polymorphonuclear neutrophils were conspicuous by light microscopy in the erythrocyte-containing BAL fluid obtained from mice at day 3 post-MI compared with day 3 postsham operation ( Figure 2F ). These results suggested that impaired gas exchange post-MI is not solely attributable to hemodynamic changes but is in part attributable to neutrophil infiltration of the lung that induces an inflammatory response and, hence, increased endothelialalveolar permeability.
IL-1β Mediates Neutrophil Infiltration Into the Alveolar Space After MI
Next, we examined factors responsible for the substantial recruitment of blood neutrophils into the alveolar space. Previous studies implicated neutrophil adhesion to vascular endothelial cells in the pathogenesis of pulmonary vascular hyperpermeability and neutrophil infiltration, mediated via the interaction of CD11/CD18 and intercellular adhesion molecule-1 (ICAM-1), followed by the transmigration of neutrophils into alveolar spaces along the CXCL-1 chemotactic gradient. 10, 11 The IL-6-triggered positive feedback loop for nuclear factor-κB signaling would then act to amplify the inflammatory response. 12 The pulmonary circulation is continuously exposed to circulating damage-associated molecular pattern molecules released from injured myocardium and capable of triggering innate immunity. Therefore, we tested the involvement of damage-associated molecular pattern molecules in our system. Lung endothelial cells (lung-ECs) were treated with tissue homogenate prepared from sham-operated or MI hearts. Tissue homogenate from sham-operated hearts did not increase the expression levels of IL-6, ICAM-1, or chemokine (C-X-C motif) ligand 1 (CXCL-1) in lung-ECs. By contrast, tissue homogenate from MI hearts increased the expression levels of these genes ( Figure 3A -C). These results suggested the involvement of factors synthesized post-MI, rather than preexisting heart constituents, in inducing the lung inflammation. We speculated the involvement of IL-1β, because IL-1β is the primary initiator of pulmonary inflammation after liver injury in mice. In addition, we 3 and others 13 reported high levels of circulating IL-1β produced and maintained by fibroblasts after cardiac injury that is then available to activate innate cells via the activation of Toll-like receptor signaling and the inflammasome. As expected, the tissue homogenate prepared from MI hearts induced an elevation of IL-6, ICAM-1, and CXCL-1 expression in lung-ECs that was almost completely blocked by anti-interleukin-1 receptor 1 (IL-1R1) antibody. Similarly, increased adhesion after pretreatment of the lung-ECs with the post-MI tissue homogenate was strongly blocked by Lung endothelial cells were sorted and cultured, then stimulated with heart lysates from sham heart or MI heart in the presence or absence of IL-1RI antibody and then, 6 hours later, the mRNA levels of inflammatory cytokines IL-6 (A), intercellular adhesion molecule-1 (ICAM-1; B), and chemokine (C-X-C motif) ligand 1 (CXCL-1; C) were examined by quantitative reverse transcription-polymerase chain reaction (RT-PCR). D, Representative photomicrograph of neutrophils adhering to lung endothelial cells (LECs). Neutrophils were labeled with carboxyfluorescein succinimidyl ester and identified by green fluorescence. Scar bar: 100 μm. E, Neutrophil adhesion on LECs pretreated with heart lysates in the presence or absence of IL-1RI antibody was quantified by fluorescence microscopy (Experiments were performed 4 times). LECs were stimulated with IL-1β in the presence or absence of IL-1RI antibody for 6 hours, and then gene expression levels of IL-6 (F), ICAM-1 (G), and CXCL-1 (H) were determined by quantitative RT-PCR. I, Representative photomicrograph of neutrophils adhering to LECs. Scar bar: 100 μm. J, Neutrophil adhesion on LECs pretreated with IL-1β in the presence or absence of IL-1RI antibody was determined by fluorescence microscopy (experiments were performed 4 times). The mice were pretreated with IL-1RI antibody or IL-1β, then subjected to sham operation or MI, at day 1 post operation, and then the mRNA levels of IL-6 (K), ICAM-1 (L), CXCL-1 (M), and IL-10 (N) in the lung tissue were examined by quantitative RT-PCR. O, The representative flow cytometry dot plots of CD11b + Gr-1 + neutrophils infiltrated into the lung. P, CD11b + Gr-1 + neutrophils infiltrated into the lung were analyzed by flow cytometry (n=5). *P<0.05; **P<0.01; ***P<0.001. Data were analyzed by Kruskal-Wallis test followed by Bonferroni post hoc analysis. Figure 3D and 3E ). IL-1β is not a direct chemoattractant for neutrophils, but it mediates neutrophil recruitment through the synthesis of IL-6, ICAM-1, and CXCL-1. 14 We confirmed that IL-1β stimulated the expression of IL-6, ICAM-1, and CXCL-1 in lung-ECs ( Figure 3F -H) and neutrophil adhesion to lung-ECs ( Figure 3I and 3J), both of which were blocked by IL-1R1 antibody-mediated neutralization. The increase in lung IL-6, ICAM-1, CXCL-1 expression after MI was also blocked by IL-1R1 antibody, and IL-1β stimulated lung IL-6, ICAM-1, and CXCL-1 expression in the absence of MI ( Figure 3K-M) . IL-1R1 antibody-mediated neutralization further stimulated an increase in lung IL-10 expression after MI although IL-1β alone had no effect on lung IL-10 expression in the absence of MI ( Figure 3N ). Finally, the neutrophil accumulation in lung was attenuated by IL-1R1 antibody after MI and stimulated by IL-1β in the absence of MI ( Figure 3O and 3P).
IL-1R1 antibody (
Inflammation in the lung after MI could be caused by either cardiac injury or an elevation in lung capillary pressure. 15 To exclude the confounding effects of an elevated LVEDP (=lung capillary pressure) resulting from the induction of a large MI, we examined lung inflammation in a myocardial ischemia-reperfusion model, in which infarct size was small, and LVEDP was not significantly elevated 2 (Online Figure V) . Results with this model revealed that even a small MI induced neutrophil accumulation in the lung, suggesting that cardiac injury alone suffices to induce inflammatory responses in the lung after MI. We also examined the lung inflammation after transverse aortic constriction (TAC), which results in much less cardiac inflammation compared with the MI model, but LVEDP elevated to the same degree as with a large MI model (permanent ligation). We found that TAC also induced neutrophil accumulation in the lung, confirming that both cardiac injury and elevated lung capillary pressure contribute to the neutrophil accumulation in the lung and that both circulatory and locally produced IL-1β could act as the primary initiator of pulmonary inflammation after MI.
Characterization of Lung NK Cells
The number of leukocytes in lung tissues gradually increased after MI, reaching significance at day 14 ( Figure 4A ), whereas the number of NK cells ( Figure 4B ) and the component ratio of NK cells ( Figure 4C ) increased at day 4 post-MI, and peaked at days 7 to 14. The number of NKT cells did not change during the time-course of this study ( Figure 4D) . A comparison of NK-cell numbers between lung and heart tissues showed a larger number in lung than in heart in both sham-operated and day 7 post-MI tissues ( Figure 4E ). There was also a substantial overlap between NKp46-positive cells and NK1.1positive cells among CD45 + CD3 − cells in peripheral blood, spleen, and lung ( Figure 4F ). NK-cell maturation is a 4-stage process as follows: CD11b low CD27 low → CD11b low CD27 high → CD11b high CD27 high → CD11b high CD27 low . 16 In this study, >80% of the lung NK cell population comprised CD11b high CD27 low cells, implying that lung NK cells maintain a terminally mature phenotype compared with spleen NK cells ( Figure 4G ). The remaining 20% of lung NK cells were positive for CD107a, a marker of cytotoxic activity ( Figure 4H and 4I) , and not >1% of NK cells were positive for IFN-γ ( Figure 4J and 4K) .
Neither the maturation status of NK cells nor the populations of CD107a-positive and IFN-γ-positive NK cells were changed after MI in lung and spleen.
Genetic Ablation of NK-Cell Worsen High-Permeability Pulmonary Edema After MI
Next, we examined the role of lung NK cells in post-MI lung inflammation. Indexes of high-permeability pulmonary edema, BAL albumin ( Figure 5A ), BAL protein ( Figure 5B ), BAL cell number ( Figure 5C ), lung wet/dry weight ( Figure 5D ), the thickness of the alveolar-capillary wall in the lung ( Figure 5E and 5F), lung MPO activities ( Figure 5G) , and BAL IL-6 levels ( Figure 5H ) deteriorated in DT-treated NKDTR/ EGFP-transgenic mice compared with PBS-treated NKDTR/ EGFP-transgenic mice. Adoptive transfer of NK cells from WT mice thus rescued the worsened post-MI lung inflammation observed for DT-treated NKDTR/EGFP-transgenic mice.
Antibody Depletion of NK-Cell Worsens High-Permeability Pulmonary Edema After MI
To confirm our initial observations, we used 2 different antibodies, anti-NK1.1 and anti-asialo GM1, to deplete NK cells in vivo selectively and conditionally (Online Figure IIC 
Mechanism Underlying the Protection of Alveolar-Capillary Wall by NK Cells
We investigated the underlying mechanism of alveolarcapillary wall protection by NK cells in the setting of MI using NKDTR/EGFP-transgenic mice. DT-mediated depletion of NK cells further increased the expression of IL-1β, IL-6, CXCL-1, and ICAM-1 in the lungs at day 3 and day 7 post-MI ( Figure 7A-D) . Interestingly, an increase in the expression of IL-10 in the lung after MI was blunted in DT-treated NKDTR/EGFP-transgenic mice ( Figure 7E ) to half the level in the lung of PBS-treated NKDTR/EGFP-transgenic mice after MI. Furthermore, neutrophil infiltration in the lung was exaggerated in DT-treated NKDTR/EGFP-transgenic mice compared with PBS-treated NKDTR/EGFP-transgenic mice after MI ( Figure 7F and 7G) . We also examined the localization of NK cells in the lung (Online Figure VII) . In healthy mice, NK cells were not associated with pulmonary vasculature; however, after MI, NK-cell accumulation was apparent around the vasculature.
Based on the experiments thus far, we hypothesized that the alveolar-capillary barrier stabilization by NK cells was mediated through paracrine secretion of IL-10. To investigate this, we examined IL-10 expression from the NK cells of IL-10-Venus reporter mice. Flow cytometry analysis revealed a higher proportion of IL-10-positive NK cells in lung than in spleen, and an increase in lung after MI from 9.8±0.6% in sham-operated lung to 17.6±0.8% in post-MI lung ( Figure 8A and 8B). Consistent with this result, mRNA levels of IL-10 from sorted lung NK cells were significantly higher than those in splenic NK cells and mRNA levels of IL-10 from sorted lung and splenic NK cells increased in response to MI ( Figure 8C ). Immunohistochemistry analysis at day 7 post-MI clearly demonstrated that IL-10 is scarcely expressed on splenic NK cells but is frequently (≈50%) expressed on lung NK cells ( Figure 8D and 8E) .
Finally, we examined whether IL-10 produced by NK cells affects endothelial permeability. IL-10 suppressed both IL-1β-induced expression of IL-6, ICAM-1, and CXCL-1 in lung-ECs and IL-1β-induced neutrophil adhesion to lung-ECs (Online Figure VIIIA-E) . Confluent monolayers of lung-ECs cultivated on Transwell filter inserts were treated with IL-1β, and the permeability of the monolayer to fluorescein isothiocyanate (FITC)-dextran was determined at several time points. IL-1β-mediated dextran leakage was blocked by IL-10 (Online Figure VIIIF) . Next, NK cells sorted from wild-type and IL-10 knockout mice were added to the lower chamber. Notably, the IL-1β-mediated dextran leakage was blocked only by coculture with NK cells sorted from wild-type mice and not by those cells sorted from IL-10 knockout mice ( Figure 8F ), confirming an effect on endothelial cell permeability.
Consistent with this, adoptive transfer of NK cells from IL-10 knockout mice failed to rescue the deteriorated lung Figure 5 . NK cells protects against pulmonary vascular hyperpermeability and injury induced by myocardial infarction (MI). NK cells were depleted by diphtheria toxin (DT) injection 1 day before surgery to induce myocardial infarction in the NKDTR/enhanced green fluorescent protein (EGFP) mice. NK cells were then purified from wild-type and interleukin (IL)-10 knockout mice and transferred into the NKDTR/EGFP mice injected with DT. The bronchoalveolar lavage (BAL) fluid (BALF) albumin (A), total protein levels (B), and total leukocyte number (C) recovered from BALF were quantified at day 7 after MI. D, Lung wet/dry weight ratio was examined at day 7 after MI. E and F, Histological sections of H&E-stained lung tissue at day 7 after MI. Histological score was also quantified. Scale bar: 100 μm. G, Myeloperoxidase activity in lung tissue was determined at day 7 after MI. H, BALF IL-6 protein levels were examined by ELISA at day 7 after MI (n=7-9). NS indicates not significant; *P<0.05; **P<0.01. Statistical analysis was performed using Kruskal-Wallis tests followed by Bonferroni post hoc analysis.
phenotype observed for DT-treated NKDTR/EGFP-transgenic mice ( Figure 5A-H ).
Discussion
We dealt with an interesting concept, exploring an important and neglected topic: the pathogenesis of cardiogenic pulmonary edema after MI. Acute cardiogenic pulmonary edema after MI is thought to arise when abnormally high pulmonary capillary pressure induces the characteristic accumulation of low-protein fluid in the interstitial and alveolar spaces of the lung associated with this disorder. However, we found that nonreperfused murine MI causes protein-rich alveolar edema accompanied by neutrophil-predominant infiltration. Erythrocyte-containing BAL fluid was obtained from mice at day 3 post-MI, suggesting that alveolar-capillary barrier broke down. Therefore, we proposed the novel concept that impaired gas exchange post-MI is not solely attributable to hemodynamic changes but is in part attributable to cellular infiltration of the lung that prompts an inflammatory response and, hence, increased endothelial-alveolar permeability.
Although the underlying immunologic mechanisms of remote lung injury after sepsis 17 and severe acute pancreatitis 18 are beginning to emerge, little attention has been paid to the inflammatory mechanism behind these severe abnormalities in respiratory gas exchange after cardiogenic pulmonary edema. Our present data introduce the concept that IL-1β sensitizes lung-ECs to neutrophil adhesion, resulting in an increased chance of neutrophil trafficking from the intravascular environment into the interstitial and alveolar compartments. Experiments in small MI model (no LVEDP Figure 6 . Depletion of NK cells with anti-NK1.1 antibody aggravates pulmonary vascular hyperpermeability and injury induced by myocardial infarction (MI). NK cells were depleted with anti-NK1.1 antibody 1 day before MI in the wild-type mice. Echocardiography and bronchoalveolar lavage (BAL) fluid (BALF) recovery were performed at day 7 after MI. Echocardiographic analysis of fractional shortening (FS; A) and left ventricular end-diastolic diameter (LVEDD; B) at day 7 after MI or sham operation (n=7-8). C, Infarct size determined with Azan staining of sections (n=7-8). The BALF albumin (D), total protein levels (E), and total leukocyte number (F) recovered from BALF, and lung wet/dry weight ratio (G) were quantified at day 7 after MI (n=6-8). H, Myeloperoxidase activity in the lung tissues was determined at day 7 after MI (n=5). I, Histological score was quantified. J, Histological sections of H&E-stained lung tissue at day 7 after MI (n=6-8). Scale bar: 100 μm. K, BALF interleukin-6 protein levels were determined at day 7 after MI (n=6). NS indicates not significant; *P<0.05; **P<0.01. Statistical analysis was performed using Kruskal-Wallis tests followed by Bonferroni post hoc analysis. February 14, 2014 elevation/moderate myocardial inflammation) and TAC model (LVEDP elevation with mild myocardial inflammation) supported both the infarcted myocardium and pulmonary capillary ECs exposed to high microvascular pressure, which are the source of IL-1β.
The present study reveals a critical role for pulmonary NK cells in protecting lungs from the development of cardiogenic pulmonary edema after MI. It was surprising that NK cells play a minor effect on myocardial remodeling where inflammatory activation is marked, associated with >10-fold increases in NK cells number and >100-fold increases in myocardial leukocytes but is critical in a process involving much lower levels of inflammatory activation, in which NK cells and inflammatory leukocyte numbers seem to increase only by 30% to 40% in the lungs of infarcted animals. Notably, the number of NK cells in lung was 20-fold higher than that in heart.
The pulmonary NK cells, which have a CD11b high CD27 low mature phenotype and express IL-10, translocate to the site of vascular inflammation after MI. The unique pulmonary environment promotes the development of NK cells with a lung-specific phenotype. 8, 19 For example, microbes entering the neonatal lung 20 could specifically prime the resident NK cells, possibly explaining why lung NK cells have a more mature phenotype and express IL-10. Unlike in the case of K. Pneumoniates infection, 21 there was no significant change in the frequency of CD107a-positive (a marker for degranulation of NK cells) or IFN-γ-positive NK cells in the lung in response to MI in this study. Instead, the frequency of lung IL-10-producing NK cells increased >2-fold after MI. IL-12 is known to induce IL-10 production from NK cells via a STAT4-dependent, T-bet-independent pathway, [22] [23] [24] and MI induces a local and systemic cytokine storm, 2,3,6 including IL-12, which may further promote NK cells expressing IL-10.
There is a bidirectional interaction between NK cells and neutrophils, whereby neutrophil stimulates translocation of NK cells to inflamed vasculature where neutrophils are accumulated. NK cells also induce neutrophil apoptosis via an NKp46-and Fas-dependent mechanism, 25 and this may be involved in the resolution of acute inflammation. In the present study, we demonstrated an unreported interaction between NK cells and neutrophils via a paracrine secretion of IL-10. NK cells are a major IL-10 source in the lung and IL-10 secreted from lung NK cells alleviates the increased permeability of the inflamed alveolar-capillary barrier after MI. To support our hypothesis, adoptive transfer of NK cells from IL-10 knockout mice failed to rescue the pulmonary phenotype observed for NK cell-depleted mice after MI. IL-10 has been shown to suppress nuclear factor-κB, P38 mitogen-activated protein kinases, and the cytokine mRNAstabilizing protein 36-kDa RNA binding protein (HuR), 26 as well as inhibit the production of numerous proinflammatory cytokines (tumor necrosis factor-α, IL-1β, IL-6), chemokines (CXCL-1, CXCL-2), and adhesion molecules (ICAM-1) that are known to mediate sequestration of neutrophils into the lung, neutrophil adhesion to ECs, and transendothelial migration of neutrophils. 11 IL-10 also attenuates the inflammatory response by increasing the expression of anti-inflammatory proteins including IL-1 receptor antagonist and soluble tumor necrosis factor-α receptor, and by decreasing the expression of major histocompatibility complex and costimulatory molecules on antigen-presenting cells. 27 P38 mitogen-activated protein kinases activation in neutrophils plays a key role in the migration of neutrophils into airways. 28 Thus, IL-10 may directly suppress such migration by suppressing P38 mitogenactivated protein kinases activation in neutrophils.
Beneficial effects of early systemic IL-10 administration on pulmonary neutrophil accumulation and lung edema after injury have been reported in various models. Intravenous administration of IL-10 protects against hepatic ischemiareperfusion-induced lung injury by inhibiting lung nuclear factor-κB activation and the resulting pulmonary neutrophil accumulation and lung edema. 11 In a porcine model of acute bacterial pneumonia, local expression of IL-10 suppressed lung edema and neutrophil invasion, resulting in significantly reduced lung damage. 29 These findings suggested that the protective role of IL-10 on the alveolar-capillary barrier is universal. However, the impact of systemic IL-10 is determined by the timing of application and the underlying disease, whereby in states of sterile inflammation it may be beneficial but deleterious in infection. 30 In this study, we demonstrated that post-MI pulmonary edema engaged NK cells in an IL-10-mediated immunoregulatory circuit that functions to alleviate pulmonary edema.
How does MI lead to neutrophil attraction in the lung but not in other organs? Such selectivity is most likely because of vascular bed heterogeneity and unique properties of the pulmonary circulation. Even under physiological conditions, Figure 8 . NK cells affect lung endothelial permeability in an interleukin (IL)-10-dependent manner. (A, B) Flow cytometric analysis of IL-10 expression among NK cells from spleen and lung at day 7 after myocardial infarction (MI) in the IL-10-Venus reporter mice. Cells were gated on NK1.1 + CD3 − lymphocytes (n=4). C, NK cells were sorted from spleen and lung at day 7 post MI, the expression level of IL-10 was quantified by quantitative reverse transcription-polymerase chain reaction (n=4). D, Spleen and lung sections were stained with GFP (green) and NK1.1 (red) antibodies in the IL-10-Venus reporter mice at day 7 after MI. Scale bar: 50 μm. E, Percentage of IL-10 + cells among NK cells in the spleen and lung (n=5). *P<0.05; **P<0.01; ***P<0.001. Data (B, C, and E) were analyzed by Mann-Whitney U tests. F, Confluence monolayer lung endothelial cells (LECs) were cultured on the Transwell inserts, NK cells sorted from wild-type and IL-10 knockout mice were added to the lower chamber. LECs were stimulated with IL-1β for 22 hours, then fluorescein isothiocyanate (FITC)-dextran was added into the top chamber and the cells were incubated for up to 60 minutes. The fluorescence intensity of the bottom chamber was analyzed on a fluorescence plate reader with filters appropriate for 485 nm and 535 nm excitation and emission, respectively. *P<0.05; **P<0.01 vs Control group; #P<0.05 vs IL-1β-treated groups. Statistical analysis was performed using Kruskal-Wallis tests followed by Bonferroni post hoc analysis. February 14, 2014 neutrophils must stop several times and change their shape to transverse the small pulmonary capillaries. 31 This increases the transit time through the pulmonary capillary bed and, as a consequence, induces a significant 40-to 100-fold neutrophil accumulation in the lung. 32 Activated neutrophils lose their ability to deform, mainly because of the intracellular polymerization of actin filaments. As a result, transition time through the pulmonary vasculature prolongs even further, ensuring sequestration into the lung. Using intravital microscopy, Schmidt et al 17 recently demonstrated that sepsis-mediated acute lung injury is initiated by degradation of the pulmonary endothelia glycocalyx, leading to neutrophil adherence and inflammation. This glycocalyx forms an endothelial surface layer that acts as a barrier to circulating cells and large molecules. Endothelial glycocalyx degradation-associated neutrophil retention seems to be unique in lung, because lipopolysaccharide caused a rapid loss in the pulmonary endothelial surface layer but cremasteric endothelial surface layer thickness was unchanged.
In summary, we demonstrated the novel finding that NK cells play a counter-regulatory role in remote lung injury associated with MI via a paracrine secretion of IL-10 (Online Figure X) . The alveolar macrophage and dendritic cells also increased in the lung in the late phase after MI, which may be involved in the chronic lung remodeling. This is consistent with previous finding, in which chronic heart failure induces lung fibrosis and macrophages infiltration. 33 The hope is that identifying these major components of both proinflammatory and local counter-regulatory mechanisms against an inflammatory change in microvascular permeability in the lung may help to identify novel pharmacological targets for congestive heart failure on MI and in more general settings involving other pathogeneses.
